Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target
Menghua Zhou, Chaoqun Wang, Shounan Lu, et al.
EBioMedicine (2021) Vol. 67, pp. 103375-103375
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature
Priyanka Banerjee, Niyanshi Gaddam, Vanessa Chandler, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 10, pp. 1400-1414
Open Access | Times Cited: 43
Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives
Siyu Hou, Yuanchun Zhao, Jiajia Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Immunobiology of cholangiocarcinoma
Jennifer L. Tomlinson, Juan W. Valle, Sumera I. Ilyas
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 867-875
Open Access | Times Cited: 31
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging
Marina Baretti, Soumya Shekhar, Vaibhav Sahai, et al.
Hepatology Communications (2025) Vol. 9, Iss. 3
Open Access | Times Cited: 1
Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
Ashwin Ajith, Kenza Mamouni, Daniel D. Horuzsko, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 19
Heterogeneity of Cholangiocarcinoma Immune Biology
Francesca Vita, Irene Olaizola, Francesco Amato, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 846-846
Open Access | Times Cited: 18
IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway
Menghua Zhou, Hongjun Yu, Miaoyu Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 777-790
Open Access | Times Cited: 7
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
The Functional Roles of Immune Cells in Primary Liver Cancer
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 6, pp. 826-836
Open Access | Times Cited: 27
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Xianzhe Yu, Lingling Zhu, Ting Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation
Stavros P. Papadakos, Nikolaos Machairas, Ioanna Ε. Stergiou, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2036-2036
Open Access | Times Cited: 13
Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1912-1912
Open Access | Times Cited: 21
Immunomodulatory Effects of Atractylodes lancea in Healthy Volunteers with Dosage Prediction for Cholangiocarcinoma Therapy: A Modelling Approach
Teerachat Saeheng, Juntra Karbwang, K Na‐Bangchang
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 198-198
Open Access
Nab-Paclitaxel Promotes Radiosensitization by Inducing DNA Damage and Inhibiting Macrophage M2 Polarization in Cholangiocarcinoma
Ningyu Wang, Xiangping Mei, Yang Cao, et al.
Cancer Biotherapy and Radiopharmaceuticals (2025)
Closed Access
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Immunity (2025)
Closed Access
Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
Yu Xu, Bing Wang, Yue Huang, et al.
Advanced Science (2025)
Open Access
External validation of plasma CSF1 as a preoperative prognostic marker in patients with resectable intrahepatic cholangiocarcinoma
A. Akiki, Hanna Jacobsson, Ghada Nouaïria, et al.
European Journal of Surgical Oncology (2025), pp. 110123-110123
Open Access
The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15563-15563
Open Access | Times Cited: 10
C/EBPα mediates the maturation and antitumor functions of macrophages in human hepatocellular carcinoma
Yongchun Wang, Zhixiong Li, Weibai Chen, et al.
Cancer Letters (2024) Vol. 585, pp. 216638-216638
Closed Access | Times Cited: 3
Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma
Yuan Liang, Qingfa Bu, Wenhua You, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167276-167276
Closed Access | Times Cited: 3
Cholangiocarcinoma in the Era of Immunotherapy
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 8
ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway
Jialu Chen, Yue Tang, Delong Qin, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Splanchnic inflammatory syndrome and the not-so-silent risk of cancer
Richard C. Semelka, Miguel Ramalho
Gastroenterology & Hepatology Open Access (2024) Vol. 15, Iss. 3, pp. 63-64
Open Access | Times Cited: 2
Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13612-13612
Open Access | Times Cited: 10
M2‐polarization‐related CNTNAP1 gene might be a novel immunotherapeutic target and biomarker for clear cell renal cell carcinoma
Weiquan Li, Xiangui Meng, Hongwei Yuan, et al.
IUBMB Life (2022) Vol. 74, Iss. 5, pp. 391-407
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top